Skip to content
Screener

Mannkind MNKD Other Income (Expense)

Other Income (Expense) at other companies

Eli Lilly logo
Eli LillyLLY
$269M+399%
LQD
Liquidia CorporationLQDA
-$4.72M-60.5%
Lexicon Pharmaceuticals logo
Lexicon PharmaceuticalsLXRX
$1.72M-6.1%
Omada Health logo
Omada HealthOMDA
$1.75M+280%
Mineralys Therapeutics, Inc. logo
Mineralys Therapeutics, Inc.MLYS
$6M+168%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$5.8M-41.1%

Other financials

Income statement

See full
Revenue$109.4M+42.9%
Gross profit$95.0M+32.0%
Operating income-$350.0K-107%
Net income-$19.0M-2,949%
EPS (diluted)-$0.06

Balance sheet

See full
Cash & equivalents$52.9M-7.2%
Total debt$11.8M-7.5%
Total equity-$67.2M-22.1%
Total assets$732.3M+77.9%

Cash flow

See full
Operating cash flow-$18.4M-305%
CapEx$5.1M+355%
Free cash flow-$23.5M-399%

Valuation

See full
Market cap$1.25B+17.8%
Enterprise value$1.21B+18.9%
P/S3.2×-0.3×

Profitability

See full
Gross margin89.8%-4.8pp
Operating margin23.3%+3.1pp
Net margin9.3%
FCF margin13.8%

Returns & leverage

See full
Return on equity44.2%
Debt / equity-0.2×
Current ratio1.7×-0.8×

Where this comes from

Reported directly by Mannkind in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The source filing: Mannkind’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:07 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335054
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Interest expense on financing liability(2,414)(2,433)(4,807)(4,843)
Loss on settlement of debt(917)
Other expense(4,992)(7,769)
Total other expense(18,788)(4,359)(33,486)(13,035)
(Loss) income before income tax (benefit) expense(19,138)940(35,504)14,557
Income tax (benefit) expense(106)272147731
Net (loss) income$(19,032)$668$(35,651)$13,826
Net (loss) income per share – basic$(0.06)$0.00$(0.12)$0.05

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Mannkind's other income (expense)?
Mannkind (MNKD) reported other income (expense) of -$18.79M in Q2 2026.
How has Mannkind's other income (expense) changed year-over-year?
Mannkind's other income (expense) decreased by 331.0% year-over-year, from -$4.36M to -$18.79M.
What is the long-term trend for Mannkind's other income (expense)?
Over 4 years (2021 to 2025), Mannkind's other income (expense) has grown at a 2.5% compound annual growth rate (CAGR), from -$33.9M to -$37.39M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Ask your AI about Mannkind's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude